Alejandra Watson
President of The Pyruvate Kinase Deficiency International Alliance
Alejandra Watson is a dedicated advocate, educator, and community leader supporting individuals affected by hemolytic rare diseases. A mother of three, she co-founded the first international PKD support group in 2013 and played a key role in developing the International PKD Guidelines published in The Lancet Hematology.
As President of the Pyruvate Kinase Deficiency International Alliance, Alejandra drives global efforts in awareness, education, and advocacy. During her collaboration with Agios Pharmaceuticals’ Advocacy Council, she contributed to the Communications White Paper and Life Phase Model, both presented at leading hemolytic platforms, including ASH, EHA, and NORD. She also works closely with Red Cell Revolution (RCR) and The Rare Anaemias International Network (RAIN) to advance research and treatment options.
